Genes displaying significantly altered expression between A-L and C-L samples that overlap with previously published Ovarian Cancer Prognostic Profile (OCPP) [6] or the Chemotherapy Response Profile (CRP) [10].

Fold change is positive if higher in carcinoma-like samples. Favorable indicates whether the directional fold change predicts favorable or unfavorable outcome for the C-L samples.若癌样样本（carcinoma-like samples）中的表达水平更高，则折叠变化（fold change）为正值。“良好（Favorable）”用于指示该方向的折叠变化对癌样样本的结局是预测为有利还是不利。